Search Results - "van der Griend, René"

Geriatric assessment in older patients with a hematologic malignancy: a systematic review by Scheepers, Ellen R M, Vondeling, Ariel M, Thielen, Noortje, van der Griend, René, Stauder, Reinhard, Hamaker, Marije E

“…The aim of this systematic review is to give an update of all currently available evidence on the relevance of a geriatric assessment in the treatment of older…”
Get full text

Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study by WIJERMANS, Pierre, SCHAAFSMA, Martijn, SONNEVELD, Pieter, TERMORSHUIZEN, Fabian, AMMERLAAN, Rianne, WITTEBOL, Shulamiet, SINNIGE, Harm, ZWEEGMAN, Sonja, VAN MARWIJK KOOY, Marinus, VAN DER GRIEND, René, LOKHORST, Henk

“…For several decades, the treatment of elderly patients with multiple myeloma (MM) has consisted of melphalan and prednisone (MP). The Dutch-Belgium…”
Get full text

Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial by Oerlemans, Simone, Arts, Lindy Paulina Johanna, Kieffer, Jacobien M, Prins, Judith, Hoogendoorn, Mels, van der Poel, Marjolein, Koster, Ad, Lensen, Chantal, Stevens, Wendy Bernadina Catharina, Issa, Djamila, Pruijt, Johannes F M, Oosterveld, Margriet, van der Griend, René, Nijziel, Marten, Tick, Lidwine, Posthuma, Eduardus F M, van de Poll-Franse, Lonneke V

“…There has been a cultural shift toward patient engagement in health, with a growing demand from patients to access their results. The Lymphoma Intervention…”
Get full text

A prognostic model for short term adverse events in normotensive patients with pulmonary embolism by Agterof, Mariette J., Schutgens, Roger E.G., Moumli, Noureddine, Eijkemans, M.J.C., van der Griend, René, Tromp, Ellen A.M., Biesma, Douwe H.

“…Risk stratification of patients with PE has gained interest in terms of the identification of patients in whom treatment on an outpatient base can be…”
Get full text

Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position by Ekels, Afke, van de Poll-Franse, Lonneke V, Issa, Djamila E, Oosterveld, Margriet, van der Griend, René, Hoogendoorn, Mels, Koster, Adrianus, Nijziel, Marten R, Arts, Lindy P J, Posthuma, Eduardus F M, Oerlemans, Simone

“…To investigate health care utilization among patients with hematologic malignancies and its association with socioeconomic position (SEP) and compare health…”
Get full text

Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial by Arts, Lindy P J, Oerlemans, Simone, Posthuma, Eduardus F M, Issa, Djamila E, Oosterveld, Margriet, van der Griend, René, Nijziel, Marten R, van de Poll-Franse, Lonneke V

“…Randomized controlled trials (RCTs) often provide accurate estimates of the internal validity of an intervention but lack information on external validity…”
Get full text

Thrombotic micro-angiopathy due to Strongyloides stercoralis hyperinfection by Stam-Slob, Manon C., van den Beuken, Sef J.L.W., van der Griend, René, Haas, Lenneke E.M., van den Wijngaard, Jeroen P.H.M., Slavenburg, Serena, Sankatsing, Sanjay U.C.

“…Background: A parasitic Strongyloides stercoralis infection is a common disease in endemic (sub)tropical areas. It may persist for years due to auto-infection…”
Get full text

Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect by van Bladel, Esther R, Agterof, Mariëtte J, Frijling, Bernard D, van der Griend, René, Prins, Martin H, Schutgens, Roger E.G, Biesma, Douwe H

“…Abstract Introduction Traditionally, patients with pulmonary embolism (PE) are treated in-hospital until they reach an adequate international normalized ratio…”
Get full text

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma by Venhuizen, Annemarie C., Hustinx, Willem N. M., Houte, Arend-Jan van, Veth, Gerda, Griend, René van der

Get full text

Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403 by van der Spek, Ellen, van der Griend, René

Get full text

Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma by van der Spek, E, Bloem, AC, van de Donk, NW, Bogers, LH, van der Griend, R, Kramer, MH, de Weerdt, O, Wittebol, S, Lokhorst, HM

“…Department of Hematology and Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands. In vitro statins induce apoptosis in myeloma and lymphoma…”
Get full text

The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia by Van der Velden, Ankie M. T., Van Velzen-Blad, Heleen, Claessen, Anke M. E., Van der Griend, René, Oltmans, Ruud, Rijkers, Ger T., Biesma, Douwe H.

“…Objectives: To analyse the effects of ranitidine treatment on vaccination induced antibody responses in patients with chronic lymphocytic leukaemia…”
Get full text

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients by Zwaginga, Jaap J, van der Holt, Bronno, Te Boekhorst, Peter A, Biemond, Bart J, Levin, Mark-David, van der Griend, René, Brand, Anneke, Zweegman, Sonja, Pruijt, Hans F M, Novotny, Vera M J, Vreugdenhil, Art, de Groot, Marco R, de Weerdt, Okke, van Pampus, Elisabeth C M, van Maanen-Lamme, Tanja M, Wittebol, Shulamiet, Schipperus, Martin R, Silbermann, Matthijs H, Huijgens, Peter C, Luten, Marleen, Hollestein, Rene, Brakenhoff, Jan A C, Schrama, Jolanda G, Valster, Fransje A A, Velders, Gerjo A, Koene, Harry R

Get full text

Risk factors for thromboembolic complications in inflammatory bowel disease : The role of hyperhomocysteinaemia by OLDENBURG, Bas, VAN TUYL, Bas A. C, VAN DER GRIEND, René, FIJNHEER, Rob, VAN BERGE HENEGOUWEN, Gerard P

“…Inflammatory bowel disease (IBD) is associated with an increased risk for thromboembolic events. Aim of this study was to examine the relationship of…”
Get full text

Methionine loading test is necessary for detection of hyperhomocysteinemia by Van Der Griend, René, Haas, Fred J.L.M., Duran, Marinus, Biesma, Douwe H., Meuwissen, Otger J.A.T.H., Banga, Jan-Dirk

“…Hyperhomocysteinemia, defined as an elevated concentration of homocysteine in the fasting state or after methionine loading, is an independent risk factor for…”
Get full text

Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? by Oldenburg, Bas, Fijnheer, Rob, van der Griend, René, vanBerge-Henegouwen, Gerard P, Koningsberger, Jacob C

“…OBJECTIVE: Patients with inflammatory bowel disease (IBD) are at increased risk for thromboembolic events. Hyperhomocysteinemia, which is an established risk…”
Get full text

An ICU patient with spots and a peculiar pneumonia by Hamers, Patricia A H, Thijsen, Steven F T, van der Griend, René, Haas, Lenneke E M

“…This is the first report of varicella zoster virus (VZV) pneumonia in an adult patient treated with rituximab because of autoimmune haemolytic anaemia and it…”
Get full text

Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens by van der Griend, René, Biesma, Douwe H, Banga, Jan-Dirk

“…Substantial epidemiological evidence supports the vision that moderate hyperhomocysteinaemia is a graded and independent cardiovascular risk factor. The…”
Get full text

Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives by van der Griend, René, Haas, Fred J.L.M., Biesma, Douwe H., Duran, Marinus, Meuwissen, Otger J.A.Th, Banga, Jan-Dirk

“…Hyperhomocysteinaemia is an independent risk factor for atherosclerotic disease and venous thrombosis. The optimal homocysteine-lowering vitamin dose and…”
Get full text

Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? by Oldenburg, Bas, Fijnheer, Rob, van der Griend, René, vanBerge-Henegouwen, Gerard P, Koningsberger, Jacob C

“…Patients with inflammatory bowel disease (IBD) are at increased risk for thromboembolic events. Hyperhomocysteinemia, which is an established risk factor for…”
Get full text